CWM
C2C Wealth Management’s NovaBay Pharmaceuticals NBY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.8K | Buy |
98,000
+43,000
| +78% | +$24.9K | 0.05% | 82 |
|
|
2025
Q1 | $32.2K | Buy |
55,000
+4,098
| +8% | +$2.4K | 0.03% | 86 |
|
|
2024
Q4 | $30.6K | Buy |
50,902
+7,954
| +19% | +$4.78K | 0.03% | 86 |
|
|
2024
Q3 | $30.8K | Buy |
+42,948
| New | +$30.8K | 0.03% | 87 |
|
|
2022
Q4 | – | Sell |
-20,000
| Closed | -$2K | – | 178 |
|
|
2022
Q3 | $2K | Sell |
20,000
-49,080
| -71% | -$4.91K | ﹤0.01% | 172 |
|
|
2022
Q2 | $17K | Sell |
69,080
-920
| -1% | -$226 | ﹤0.01% | 185 |
|
|
2022
Q1 | $17K | Buy |
70,000
+19,000
| +37% | +$4.61K | ﹤0.01% | 205 |
|
|
2021
Q4 | $19K | Buy |
+51,000
| New | +$19K | ﹤0.01% | 222 |
|